期刊文献+

宫颈上皮内瘤样病变患者高危型HPV感染基因分型分析 被引量:2

The analysis of the infection and genotyping of the high-risk HPV in CIN patients
原文传递
导出
摘要 目的了解宫颈上皮内瘤变患者的高危型HPV的感染及其分型和不同程度宫颈病变的主要感染型别情况。方法应用型特异PCR检测宫颈癌前病变的患者的主要高危型HPV-16、18、33、58的感染及其分型情况的相关性研究。结果在本研究宫颈上皮内瘤变患者98例中,4种高危型HPV的总阳性例数为73例,HPV总的感染率为74.5%,存在多重感染。其中HPV-16、18、33、58的总感染率分别为53.1%、38.7%、17.3%和30.6%。CIN的Ⅰ/Ⅱ/Ⅲ3组患者的4种高危型HPV的感染率分别为42.9%、61.1%和93.2%。结论主要高危型HPV在宫颈上皮内瘤变患者中感染的主要型别依次为HPV16、HPV18、HPV58、HPV33,主要为HPV16和HPV18型;不同程度CIN的高危型HPV的总感染率不同,随病变程度的加重而增加。 Objective:To study the main HPV infection types and genotyping of the CIN patients. To study the prevalent HPV types in different grade of CIN. Methods:Type-specific PCR was used to detect HPV-16,18,33,58 and genotyping of cervical intraepithelial neoplasia (CIN). Results:There were 73 samples screened for the presence of HPV-DNA form 98 patients. The positive rate of total HPV was 74.5%. The infection rates of the four HPV types were as follows:HPV16 (53.1%),HPV18 (38.7%),HPV33 (17.3%),HPV58 (30.6%). The Positive rates of total HPV in different grade of CIN were 42.9%,61.1% and 93.2% respectively. Conclusion:The prevalent HPV types of CIN from highest to lowest order were as follows:HPV16,HPV18,HPV58 and HPV33. The positive rates of total HPV in different grade of CIN were different,increasing with the seriousness of cervical neoplasia lesions.
出处 《中国优生与遗传杂志》 2010年第2期19-20,共2页 Chinese Journal of Birth Health & Heredity
关键词 宫颈上皮内瘤样病变 人乳头瘤病毒 基因分型 Cervical intraepithelial neoplasia (CIN) Human papillomavirus (HPV) Genotyping
  • 相关文献

参考文献5

  • 1Bulkmans NW, Bleeker MC, Berkhof J, et al. Prevalence of types 16 and 33 is increased in high -risk human papillomavirus positive woman with cerical intraepithelial neoplasia grade 2 or worse[ J]. Int J Cancer,2005,117:177 - 181.
  • 2Hong D, et alDistribution of human papillomavirus genotypes in the patients with cervical carcinoma and its precursors in Zhejiang Province,China[J]. Int J Gyneeol Cancer,2008,18( 1 ) :104 - 109.
  • 3Beerens E, Van Renterghem L, Praet M, et al. Haman papillomavirus DNA detection in women with primary abnormal cytology of the cervix : prevalence and distribution of HPV genotypes [ J ]. Cytopathology,2005,16(4) :199 -205.
  • 4张燕玲,乔志强,李隆玉,万磊.宫颈癌及癌前病变患者人乳头瘤病毒感染率的临床分析[J].实用癌症杂志,2005,20(2):161-163. 被引量:16
  • 5Munoz N, Bosch FX, Castellsague X, et al. Against which human papillomavirus types shall we vaccinate and screen? The international perspective[ J]. Int J Cancer,2004., 111:278 - 285.

二级参考文献8

  • 1李淑敏,章文华,吴令英,赵芳辉,黄曼妮,李楠,陈凤.人乳头状瘤病毒负荷量与子宫颈癌及其癌前病变关系的初步研究[J].中华妇产科杂志,2004,39(6):400-402. 被引量:76
  • 2Mario P,Irena J,Katja S,et al.Hybrid Capture Ⅱ HPV Test detects at least 15 human papillomavirus genotypes not included in its current high-risk probe cocktail[J].Journal of Clinical Viology,2002,41(15):89.
  • 3Chan JK, Jeongmi KJ, Misun P, et al. HPV oligonucleotide microarray-based detection of HPV genotypes in cervical neoplastic lesions[J].Gynecol Oncol 2003,89:210.
  • 4Simona V,Monica C,Francesca B,et al.Human papillomavirus DNA testing by PCR-ELISA and hybrid capture Ⅱ from a single cytological specimen:concordance and correlation with cytological results[J].Journal of Clinical Viology,2002,32(25):177.
  • 5Dulce MH,Laura OB,Miriam GJ,et al.Association between high-risk human papillomavirus DNA load and precursor lesions of cervical cancer in Mexican women[J].Gyne Onco,2003,90:310.
  • 6Keng FH,Soon HM,Jenn RH,et al.Clincal significance of serum human papillomavirus DNA in cervical carcinoma[J].Obstet Gynecol,2003,102:1344.
  • 7Agnethea MJ,Patrik KM,Nathalie Y,et al.Viral load of huamanvirus 16 as a determianant for development of cervical carcinoma in situ:a newt case-control study[J].The Lancet,2001,6(355):2189.
  • 8William WA.Life style,environmental and genetic susceptibility to cervical cancer[J].Toxicology,2004,198:117.

共引文献15

同被引文献22

  • 1陶萍萍,卞美璐,欧华,陈庆云,李敏,刘军.导流杂交基因芯片技术在人乳头状瘤病毒检测中应用的研究[J].中华妇产科杂志,2006,41(1):43-47. 被引量:132
  • 2何进才,周小梅,黄涛,任维.反向杂交法检测23种人乳头瘤病毒型别的研究[J].中华检验医学杂志,2007,30(1):44-47. 被引量:10
  • 3Adam E, Berkova Z, Daxnemva Z, et al. Papillomavirus detection: demographic and behavioral characteristics influencing the identifica- tion of cervical disease. Am J Obstet Gynecol, 2000, 182(2) : 257- 264.
  • 4Bosch FX, Manos MM, Munoz N, et al. Prevalence Of human papil- lomavims in cervical cancer: a worldwide perpective, hatemational bio- logical study on cervical cancer(IBSCC) Study Group. J Nail Cancer Inst, 1995, 87(11): 796-802.
  • 5Castellsague X, Dtaz M, de Sanjose S, et al. Worldwide human pa- pillomavirus etiology of cervical adenocarcinoma and its cofactors: im- plications for screening and prevention. J Nail Cancer lnst, 2006, 98 (5) : 303-315.
  • 6Wright TC Jr, Massad LS, Dunton CJ, et al. 2006 Consensus guide- lines for the management of women with abnormal cerviacl screening tests. J Low Genit Tract Dis, 2007, 11(4) : 201-222.
  • 7Schiffman MH, Herrero R, Hildesheim A, et al. I-IPV DNA testing in cervical cancer screening. JAMA, 2000, 283(1): 87-93.
  • 8Chaudhary AK, Pandya S, Mehrotra R, et al. Comparative study be- tween the Hybrid Capture I] test and PCR based assay for the detec- tion of human papillomavirus DNA in oral submucous fibrosis and oral squamous cell carcinoma. Virol J, 2010, 7: 253.
  • 9Castle PE, Schiffman M, Burk RD, et al. Restricted cross-reactivity of hybrid capture 2 with nononcogenic human papillomavirus types. Cancer Epidemiol Biomarkers Prev, 2002, 11 ( 11 ) : 1394-1399.
  • 10Hart KW, Williams OM, Thelwell N, et al. Novel method for detec- tion, typing, and quantification of human papillomaviruses in clinical samples. J Clin Microbiol, 2001, 39(9): 3204-3212.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部